Both in Pharmaceuticals
Definium Therapeutics vs Xenon Pharmaceuticals
Over the past year DFTX returned +112.6% and XENE returned −3.8%; their daily moves had a correlation of 0.20.
DFTX +112.6% XENE −3.8%Growth of $1, one year, split-adjusted
| Metric | DFTX | XENE |
|---|---|---|
| Price | $32.70 | $39.19 |
| Market cap | $4.39B | $3.80B |
| Today | −2.13% | +2.51% |
| 1 month | −8.2% | +7.2% |
| 6 months | +39.6% | −33.1% |
| Year to date | — | −12.6% |
| 1 year | — | −4.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.05B | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 56.9% | 82.7% |
| Short % of float | 7.6% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).